• 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

    Source: Buzz FX / 20 Feb 2025 03:51:12   America/Chicago


    4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Receives Consensus Recommendation of "Moderate Buy" from Brokerages Written by MarketBeat February 20, 2025 Share Link copied to clipboard. Shares of 4D Molecular Therapeutics, Inc.
    Read more...
Share on,